Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection (Q33618621)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection |
scientific article |
Statements
1 reference
Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejection (English)
1 reference
R R Bartlett
1 reference
M Dimitrijevic
1 reference
T Mattar
1 reference
T Zielinski
1 reference
T Germann
1 reference
E Rüde
1 reference
G H Thoenes
1 reference
C C Küchle
1 reference
H U Schorlemmer
1 reference
E Bremer
1 reference
1 January 1991
1 reference
1 reference
1-2
1 reference
10-21
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference